The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
Investors understand that their principal will be at very high risk
Category
Sector Funds
Launch Date
05-Jun-04
Scheme Benchmark
NA
AUM ( in Cr.)
8,080.97
portfolio price to book value
8.65
investing style?
Large Growth
fund manager?
Sailesh Raj Bhan
inception date (regular plan)
expense ratio (regular plan) %
1.82